NovoCure Limited Total Assets
NovoCure Limited (NVCR) had Total Assets of $795.19 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-23
- 2026-06-30: Assets $795.19M.
- 2026-03-31: Assets $787.93M.
- 2025-12-31: Assets $804.33M.
- 2025-09-30: Assets $1.36B.
| Period end | Assets |
|---|---|
| 2026-06-30 | $795.19M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $787.93M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $804.33M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $1.36B 10-Q · filed 2025-10-30 |
| 2025-06-30 | $1.25B 10-Q · filed 2025-07-24 |
| 2025-03-31 | $1.25B 10-Q · filed 2025-04-24 |
| 2024-12-31 | $1.24B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.22B 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.21B 10-Q · filed 2024-07-25 |
| 2024-03-31 | $1.12B 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.15B 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.15B 10-Q · filed 2023-10-26 |
| 2023-06-30 | $1.16B 10-Q · filed 2023-07-27 |
| 2023-03-31 | $1.17B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.19B 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.17B 10-Q · filed 2022-10-27 |
| 2022-06-30 | $1.16B 10-Q · filed 2022-07-28 |
| 2022-03-31 | $1.15B 10-Q · filed 2022-04-28 |
| 2021-12-31 | $1.14B 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.12B 10-Q · filed 2021-10-28 |
| 2021-06-30 | $1.10B 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.07B 10-Q · filed 2021-04-29 |
| 2020-12-31 | $1.05B 10-K · filed 2022-02-24 |
| 2020-09-30 | $431.05M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $528.94M 10-Q/A · filed 2020-10-02 |
| 2020-03-31 | $502.45M 10-Q/A · filed 2020-10-02 |
| 2019-12-31 | $479.45M 10-K · filed 2021-02-25 |
| 2019-09-30 | $443.86M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $406.19M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $370.25M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $339.79M 10-K · filed 2020-02-27 |
| 2018-09-30 | $315.51M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $309.88M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $303.48M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $265.30M 10-K · filed 2019-02-28 |
| 2017-09-30 | $262.28M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $257.04M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $264.63M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $282.08M 10-K · filed 2018-02-22 |
| 2016-09-30 | $291.09M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $250.52M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $279.02M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $307.34M 10-K · filed 2017-02-23 |
| 2015-09-30 | $173.78M 10-Q · filed 2015-10-27 |
| 2014-12-31 | $117.88M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |